N. York Charles's Insider Trades & SAST Disclosures
N. York Charles's most recent trade in Day One Biopharmaceuticals Inc was a trade of 6,625 Common Stock done . Disclosure was reported to the exchange on Feb. 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern N. York Charles.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 6,625 | 257,008 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 6,625 | 250,383 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 6,625 | 99,375 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 6,625 | 72,875 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 11.96 per share. | 15 Feb 2025 | 4,370 | 252,638 | - | 12.0 | 52,278 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 2,250 | 243,758 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 2,250 | 15,750 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 1,375 | 4,125 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 1,375 | 241,508 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 162,000 | 162,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 106,000 | 106,000 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 6,625 | 242,735 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 6,625 | 79,500 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 13.21 per share. | 15 Nov 2024 | 2,602 | 240,133 | - | 13.2 | 34,373 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 2,250 | 18,000 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 2,250 | 236,110 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 1,375 | 5,500 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 1,375 | 233,860 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 6,625 | 86,125 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 6,625 | 235,118 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 15 Aug 2024 | 2,633 | 232,485 | - | 14.0 | 36,860 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 2,250 | 228,493 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 2,250 | 20,250 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 1,375 | 226,243 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 1,375 | 6,875 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 6,625 | 227,543 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 6,625 | 92,750 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 15 May 2024 | 2,675 | 224,868 | - | 16.1 | 43,011 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,250 | 220,918 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,250 | 22,500 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 1,375 | 8,250 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 1,375 | 218,668 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 17.89 per share. | 01 May 2024 | 52,183 | 225,571 | - | 17.9 | 933,397 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 17.85 per share. | 01 May 2024 | 8,078 | 217,293 | - | 17.9 | 144,214 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 17.90 per share. | 01 May 2024 | 200 | 225,371 | - | 17.9 | 3,579 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 6,625 | 280,420 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | N. York Charles | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 6,625 | 99,375 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | N. York Charles | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 15 Feb 2024 | 2,666 | 277,754 | - | 15.2 | 40,651 | Common Stock |
| Day One Biopharmaceuticals... | York N. Charles | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 2,250 | 273,795 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | York Charles N. | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 2,250 | 24,750 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | York Charles N. | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,375 | 9,625 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Charles York N. | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,375 | 271,545 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | N. Charles York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 162,000 | 162,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | York Charles N. | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 106,000 | 106,000 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 2,250 | 268,423 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 2,250 | 29,250 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 1,375 | 266,173 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 1,375 | 12,375 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 13.86 per share. | 15 Aug 2023 | 922 | 267,501 | - | 13.9 | 12,779 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 2,250 | 31,500 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 2,250 | 265,753 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 1,375 | 263,503 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 1,375 | 13,750 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 13.12 per share. | 15 May 2023 | 955 | 264,798 | - | 13.1 | 12,532 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 17 Feb 2023 | 9,377 | 262,128 | - | 20.0 | 187,790 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 2,250 | 272,435 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 2,250 | 33,750 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 1,375 | 15,125 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 1,375 | 270,185 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 19.57 per share. | 15 Feb 2023 | 930 | 271,505 | - | 19.6 | 18,203 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 22.75 per share. | 20 Jan 2023 | 10,000 | 268,810 | - | 22.8 | 227,523 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 116,000 | 116,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 36,000 | 36,000 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.06 per share. | 20 Dec 2022 | 10,000 | 276,497 | - | 20.1 | 200,650 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.74 per share. | 21 Nov 2022 | 9,700 | 286,797 | - | 20.7 | 201,153 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 21.39 per share. | 21 Nov 2022 | 300 | 286,497 | - | 21.4 | 6,417 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 1,375 | 16,500 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 1,375 | 295,776 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 21.46 per share. | 15 Nov 2022 | 430 | 296,497 | - | 21.5 | 9,228 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 01 Nov 2022 | 10,000 | 294,401 | - | 20.0 | 200,313 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 03 Oct 2022 | 10,000 | 304,401 | - | 20.0 | 200,473 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 23.16 per share. | 01 Sep 2022 | 8,606 | 315,795 | - | 23.2 | 199,309 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 23.80 per share. | 01 Sep 2022 | 1,394 | 314,401 | - | 23.8 | 33,175 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 4,125 | 325,490 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 4,125 | 17,875 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 24.31 per share. | 15 Aug 2022 | 1,089 | 324,401 | - | 24.3 | 26,474 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 04 Aug 2022 | 10,000 | 321,365 | - | 20.1 | 200,541 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 18 Jul 2022 | 2,500 | 331,365 | - | 20 | 50,000 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 08 Jul 2022 | 1,416 | 333,865 | - | 20 | 28,320 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 01 Jul 2022 | 1,479 | 336,081 | - | 20 | 29,580 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 01 Jul 2022 | 800 | 335,281 | - | 20 | 16,000 | Common Stock |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 151,000 | 151,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Charles N. York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 22,000 | 22,000 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges